Editor’s note: Merging of the minds

16:00 EST 11 Jan 2019 | Drug Store News

DSN's editor-in-chief, Seth Mendelson, looks at how the GSK-Pfizer deal will level the playing field between retailers. generic via filter on get_the_excerpt -->

Read More

Original Article: Editor’s note: Merging of the minds


More From BioPortfolio on "Editor’s note: Merging of the minds"

Quick Search


Relevant Topics

GlaxoSmithKline is the third largest pharmaceutical company in the world, based on annual sales, which reached $37,134m in 2009. Spread over 100 countries, GSK employs 96,500 people, 13,000 of which are dedicated to research and development of the the ...

Biotechnology Business
Alliances Astrazeneca Bioethics Boehringer Clinical Research Organization Collaborations GSK Johnson & Johnson Lilly Merck Mergers and Acquisitions Nexium Novartis Pfizer Roche Sanofi ...

Generics Drugs
A generic drug (generic drugs, short: generics) is a drug defined as "a drug product that is comparable to brand/reference listed drug product in dosage form, strength, route of administration, quality and performance characteristics, and intended u...